Birgitta Versluijs

36 References 1. Landier W, Armenian S, Bhatia S. Late effects of childhood cancer and its treatment. Pediatr Clin North Am 2015;62:275–300. 2. Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health out- comes among adults treated for child- hood cancer. JAMA 2013;309: 2371–81. 3. Geenen MM, Cardous-Ubbink MC, Kre- mer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 2007;297:2705–15. 4. Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 2009;27:2328–38. 5. Garwicz S, Anderson H, Olsen JH, et al. Late and very late mortality in 5-year survivors of childhood cancer: changing pattern over four decades–experience from the Nordic countries. Int J Cancer 2012;131:1659–66. 6. Mertens AC, Yasui Y, Liu Y, et al. Pulmo- nary complications in survivors of child- hood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer 2002;95:2431–41. 7. Mulder RL, Thonissen NM, van der Pal HJ, et al. Pulmonary function impair- ment measured by pulmonary function tests in long-term survivors of child- hood cancer. Thorax 2011;66:1065–71. 8. Graves PR, Siddiqui F, Anscher MS, Movsas B. Radiation pulmonary toxi- city: from mechanisms to manage- ment. Seminars in radiation oncology 2010;20:201–7. 9. Williams JP, Johnston CJ, Finkelstein JN. Treatment for radiation-induced pul- monary late effects: spoiled for choice or looking in the wrong direction? Curr Drug Targets 2010;11:1386–94. 10. Venkatramani R, Kamath S, Wong K, et al. Correlation of clinical and dosimetric factors with adverse pulmonary outco- mes in children after lung irradiation. Int J Radiat Oncol Biol Phys 2013;86:942–8. 11. Huang TT, Hudson MM, Stokes DC, Krasin MJ, Spunt SL, Ness KK. Pulmo- nary outcomes in survivors of child- hood cancer: a systematic review. Chest 2011;140:881–901. 12. Motosue MS, Zhu L, Srivastava K, et al. Pulmonary function after whole lung ir- radiation in pediatric patients with solid malignancies. Cancer 2012;118: 1450–6. 13. Green DM, Lange JM, Qu A, et al. Pul- monary disease after treatment for Wilms tumor: a report from the national wilms tumor long-term follow-up study. Pediatr Blood Cancer 2013;60:1721–6. 14. Attard-Montalto SP, Kingston JE, Eden OB, Plowman PN. Late follow-up of lung function after whole lung irradiati- on for Wilms’ tumour. Br J Radiol 1992; 65:1114–8. 15. Oguz A, Tayfun T, Citak EC, et al. Long- term pulmonary function in survivors of childhood Hodgkin disease and non- Hodgkin lymphoma. Pediatr Blood Can- cer 2007;49:699–703. 16. Venkatramani R, Kamath S, Wong K, et al. Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation. Pediatr Blood Cancer 2014;61:1277–81. 17. Cooper Jr JA, White DA, Matthay RA. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis 1986;133:321–40. 18. Abid SH, Malhotra V, Perry MC. Radiati- on-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 2001;13:242–8. 19. Eigen H, Wyszomierski D. Bleomycin lung injury in children. Pathophysiology References 2